Abstract
Health-related quality of life (HRQL) walks hand in hand with survival as a key outcome in health care. This notion has resonated in the rhetoric of regulatory and funding authorities and clinical trials groups around the globe for decades.1–6 So why is it that quality-of-life studies so rarely affect clinical decision making?
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
